Lung Cancer - References

Provided by: Healthwise
Not yet rated

References

Citations

  1. American Cancer Society (2005). What are the key statistics for lung cancer? Detailed Guide: Lung Cancer. Available online: http://www.cancer.org/docroot/CRI/content/CRI_2_4_1x_What_Are_the_Key_Statistics_About_Lung_Cancer_15.asp?sitearea=.

  2. Miller YE (2004). Lung cancer and other pulmonary neoplasms. In L Goldman, D Ausiello, eds., Cecil Textbook of Medicine, 22nd ed., pp. 1201–1208. Philadelphia: Saunders.

  3. Crawford J (2004). Lung cancer. In DC Dale, DD Federman, eds., ACP Medicine, section 12, chap. 8. New York: WebMD.

  4. Godtfredsen NS, et al. (2005). Effect of smoking reduction on lung cancer risk. JAMA, 294(12): 1505–1510.

  5. Jablons D, et al. (2003). Neoplasms of the lung. In LW Way, GM Doherty, eds., Current Surgical Diagnosis and Treatment, 11th ed., pp. 395–407. New York: McGraw-Hill.

  6. Bain C, et al. (2004). Lung cancer rates in men and women with comparable histories of smoking. Journal of the National Cancer Institute, 96(11): 826–834.

  7. National Toxicology Program, U.S. Department of Health and Human Services (2005). Report on Carcinogens, 11th ed. Available online: http://ntp-server.niehs.nih.gov/ntp/roc/toc11.html.

  8. Annema JT, et al. (2005). Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA, 294(8): 931–936.

  9. Humphrey LL, et al. (2004). Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: An update for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 140(9): 740–753.

  10. National Cancer Institute (2005). Lung Cancer PDQ: Screening–Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/screening/lung/healthprofessional.

  11. Winton T, et al. (2005). Vinorelbine plus cisplatin vs. observation in resected non–small cell lung cancer. New England Journal of Medicine, 352(25): 2589–2597.

  12. Fox JL, et al. (2004). The effect of smoking status on survival following radiation therapy for non–small cell lung cancer. Lung Cancer, 44(3): 287–293.

  13. Dasgupta P, et al. (2006). Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proceedings of the National Academy of Sciences, 103(16): 6332–6337.

  14. Simon CJ, Dupuy DE (2005). Current role of image-guided ablative therapies in lung cancer. Expert Review of Anticancer Therapy, 5(4): 657–666.

  15. International Adjuvant Lung Cancer Trial Collaborative Group (2004). Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer. New England Journal of Medicine, 350(4): 351–360.

  16. Spira A, Ettinger DS (2004). Multidisciplinary management of lung cancer. New England Journal of Medicine, 350(4): 379–392.

  17. Schabath MB, et al. (2005). Dietary phytoestrogens and lung cancer. JAMA, 294(12): 1493–1504.

  18. Goodman GE, et al. (2004). The beta-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. Journal of the National Cancer Institute, 96(23): 1743–1750.

  19. Food and Drug Administration (2004). FDA statement on Iressa. FDA Public Health Web Notification. Available online: http://www.fda.gov/bbs/topics/news/2004/new01145.html.

  20. U.S. Food and Drug Administration (2006). FDA approves new combination therapy for lung cancer. FDA News. Available online: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01488.html.

  21. Chesnutt MS, Prendergast TJ (2005). Pulmonary neoplasms. In LM Tierney Jr et al., eds., Current Medical Diagnosis and Treatment, 44th ed., pp. 262–271. New York: McGraw-Hill.

  22. National Cancer Institute (2006). Small Cell Lung Cancer PDQ: Treatment—Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/healthprofessional.

  23. Auperin A, et al. (1999). Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. New England Journal of Medicine, 341(7): 476–484.

Other Works Consulted

  • National Comprehensive Cancer Network and American Cancer Society (2004). Lung Cancer Treatment Guidelines for Patients, version II. Available online: http://www.nccn.org/patients/patient_gls/_english/_lung/contents.asp.

  • National Comprehensive Cancer Network and American Cancer Society (2005). Non–Small Cell Lung Cancer, version 2.2005. Available online: http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf.

  • National Comprehensive Cancer Network and American Cancer Society (2005). Small Cell Lung Cancer, version 1.2006. Available online: http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdf.

  • Neville A (2004). Lung cancer. Clinical Evidence (13): 1–21.

Last Updated: 06/12/2006

© 1995-2007, Healthwise, Incorporated, P.O. Box 1989, Boise, ID 83701. ALL RIGHTS RESERVED.

This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information. For more information, click here. Privacy Policy. How this information was developed.

Was this article helpful?
Tell us what you think.

Be the first to rate!
liked it no thanks

In the Spotlight

Highly Preventable

It may be the leading cause of cancer death for both men and women in the U.S., but most lung cancers are preventable in most cases.

Learn More »

Yahoo! Groups

Join the Conversation:

Join a Yahoo! Group and discuss topics with other members of the group.

See all Cancer Groups »

Tell us what you think about Yahoo! Health - Send us your feedback